Skip to content
Research Article Open access CC BY 4.0

Myocarditis Secondary to COVID 19 Infection: A Case-Report

Gueye Khadidiatou, Seye Modou, S. Y. Sidy Lamine, Ismael Ibouroi Moina-Hanifa, Gaye Cheikh, B. A. Amadou Baro, Dioum Momar, Diop Ibrahima Bara

International Journal of Medical and Pharmaceutical Case Reports · pp. 5–9 · Published 7 Jul 2021

10.9734/ijmpcr/2021/v14i230129

Abstract

Introduction: Coronavirus disease 2019 (COVID 19) is an emerging viral infection caused by the strain of coronavirus SARS-CoV-2, primarily affecting the respiratory system. However, it can be responsible for heart damage. The aim of this work was to report a case of symptomatic myocarditis in a 53-year-old patient. Patient and Observation: We report the case of a 53-year-old patient with no particular history or cardiovascular risk factor found who had consulted in June 2020 in a hospital for dyspnea, dizziness and palpitations in whom the electrocardiogram had demonstrated ventricular tachycardia. The echocardiography was normal and coronary artery disease was ruled out on coronary angiography and antiarrhythmic treatment allowed it to regress. Two months later, after a break in therapy, this tachycardia recurred despite several electrical and chemical cardioversions. Subsequently, myocarditis was suspected. This motivated the realization of a cardiac magnetic resonance imaging (MRI) which came back in favor of myocarditis. As part of the etiological research, RT-PCR and COVID 19 serology were requested and the serology returned positive for IgG. Conclusion: COVID 19 disease is known for its respiratory manifestations. However, several cases of cardiac involvement, in particular myocardial damage, have been described and among these, a considerable proportion of arrhythmias. They can be multifactorial in origin, due to the virus itself, or the prolongation of the QT interval from various drug therapies. These arrhythmias are the source of sudden death, hence the interest of RT-PCR and COVID 19 serology, but also the need for early and appropriate management, as well as long-term monitoring of patients. cured patients.

myocarditis COVID 19 ventricular tachycardia

References (8)

  1. 1 Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper [DOI]
  2. 2 Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) [DOI]
  3. 3 Myocardial Localization of Coronavirus in COVID-19 Cardiogenic Shock [DOI]
  4. 4 Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy [DOI]
  5. 5 Characteristic Electrocardiographic Manifestations in Patients With COVID-19 [DOI]
  6. 6 A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001 [DOI]
  7. 7 Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic [DOI]
  8. 8 Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019 [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

15

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.